- Home
- ASRT vs NTRB Comparison
ASRT vs NTRB Comparison
Compare ASRT & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- NTRB
- Stock Information
- Founded
- ASRT 1995
- NTRB 2016
- Country
- ASRT United States
- NTRB United States
- Employees
- ASRT N/A
- NTRB N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- NTRB Industrial Specialties
- Sector
- ASRT Health Care
- NTRB Health Care
- Exchange
- ASRT Nasdaq
- NTRB Nasdaq
- Market Cap
- ASRT 91.3M
- NTRB 77.9M
- IPO Year
- ASRT 1997
- NTRB N/A
- Fundamental
- Price
- ASRT $0.89
- NTRB $4.50
- Analyst Decision
- ASRT Strong Buy
- NTRB
- Analyst Count
- ASRT 4
- NTRB 0
- Target Price
- ASRT $3.19
- NTRB N/A
- AVG Volume (30 Days)
- ASRT 908.1K
- NTRB 27.6K
- Earning Date
- ASRT 11-11-2024
- NTRB 12-04-2024
- Dividend Yield
- ASRT N/A
- NTRB N/A
- EPS Growth
- ASRT N/A
- NTRB N/A
- EPS
- ASRT N/A
- NTRB N/A
- Revenue
- ASRT $125,763,000.00
- NTRB $2,021,771.00
- Revenue This Year
- ASRT N/A
- NTRB N/A
- Revenue Next Year
- ASRT $1.84
- NTRB N/A
- P/E Ratio
- ASRT N/A
- NTRB N/A
- Revenue Growth
- ASRT N/A
- NTRB N/A
- 52 Week Low
- ASRT $0.73
- NTRB $2.22
- 52 Week High
- ASRT $1.80
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- ASRT 43.20
- NTRB 47.75
- Support Level
- ASRT $0.90
- NTRB $3.87
- Resistance Level
- ASRT $1.04
- NTRB $4.86
- Average True Range (ATR)
- ASRT 0.06
- NTRB 0.48
- MACD
- ASRT -0.00
- NTRB 0.08
- Stochastic Oscillator
- ASRT 14.84
- NTRB 65.05
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.